Mortality and Antipsychotic Drug Use in Elderly Patients With Parkinson Disease in Nursing Homes
- 13 June 2017
- journal article
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 18 (9) , 791-796
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Risk excess of mortality and use of antipsychoticsInternational Clinical Psychopharmacology, 2017
- Comparative risk of death in older adults treated with antipsychotics: A population-based cohort studyEuropean Neuropsychopharmacology, 2016
- Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adultsInternational Journal of Geriatric Psychiatry, 2016
- Risk of Mortality Among Patients Treated With Antipsychotic MedicationsJournal of Clinical Psychopharmacology, 2016
- Risk of Mortality Among Individual Antipsychotics in Patients With DementiaAmerican Journal of Psychiatry, 2012
- The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's diseaseMovement Disorders, 2011
- Are All Commonly Prescribed Antipsychotics Associated with Greater Mortality in Elderly Male Veterans with Dementia?Journal of the American Geriatrics Society, 2010
- The changing face of Parkinson's disease‐associated psychosis: A cross‐sectional study based on the new NINDS‐NIMH criteriaMovement Disorders, 2010
- Antipsychotic Medication Dispensing and Risk of Death in Veterans and War Widows 65 Years and OlderThe American Journal of Geriatric Psychiatry, 2007
- Psychosis in Parkinson's diseaseMovement Disorders, 2003